January 2014

Accuracy advises Gilde Healthcare Services

Gilde Healthcare Services acquires majority share in Viroclinics Biosciences from Erasmus MC.

Viroclinics Biosciences is a diagnostic and clinical trial operation service company providing diagnostic and preclinical studies along with drug development for prevention and treatment of virus infections.

More accuracy news

June 2022

Accuracy advises BC Partners

Accuracy conducted financial buy-side due diligence for BC Partners in the context of the acquisition of a majority stake in Havea. ...

June 2022

Accuracy advises Veolia

Accuracy conducted various financial advisory services in the context of Veolia's carve-out of its European Mobile Water Services division. ...